2007
DOI: 10.1007/s00403-007-0816-z
|View full text |Cite
|
Sign up to set email alerts
|

A study of the pathogenesis of Rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process

Abstract: In the present study we evaluated, in involved and clinically uninvolved skin of Rosacea, microvessels density (MVD) and total vascular area (TVA) in addition to multiple morphologic characteristics of microvessels and also mast cells (MCs) number. We examined also the relationship between angiogenesis, MCs number and disease clinicopathological data. The study included 69 patients with Rosacea. A skin biopsy with a 4-mm punch was performed from clinically involved skin in each case. In nine randomly selected … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
58
1
9

Year Published

2009
2009
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 95 publications
(70 citation statements)
references
References 31 publications
2
58
1
9
Order By: Relevance
“…A sustained increase in new blood vessel formation, known as cutaneous angiogenesis, can be seen in cutaneous disease, including primary and metastatic cutaneous malignant melanoma (Hubler and Wolf, 1976;Marcoval et al, 1997), rosacea (Aroni et al, 2008), and psoriasis (Creamer and Barker, 1995). Evidence from clinical trials suggests that VEGF, as a key cytokine in skin inflammation, is a main angiogenic mediator in psoriasis (Detmar et al, 1994;Kunstfeld et al, 2004).…”
Section: Discussionmentioning
confidence: 99%
“…A sustained increase in new blood vessel formation, known as cutaneous angiogenesis, can be seen in cutaneous disease, including primary and metastatic cutaneous malignant melanoma (Hubler and Wolf, 1976;Marcoval et al, 1997), rosacea (Aroni et al, 2008), and psoriasis (Creamer and Barker, 1995). Evidence from clinical trials suggests that VEGF, as a key cytokine in skin inflammation, is a main angiogenic mediator in psoriasis (Detmar et al, 1994;Kunstfeld et al, 2004).…”
Section: Discussionmentioning
confidence: 99%
“…In patients with rosacea, significantly increased dermal expression of the potent angiogenesis factor vascular endothelial growth factor in lesional versus nonlesional skin (88.9 vs. 55.6%, respectively) was observed. Furthermore, more microvessels were observed in lesional compared to clinically nonlesional skin, and a high microvessel density was found to be correlated with granuloma formation in the skin [19] . There was also a correlation between high vascular density and the presence of ocular manifestations [19] .…”
Section: Inhibition Of Angiogenesismentioning
confidence: 98%
“…Furthermore, more microvessels were observed in lesional compared to clinically nonlesional skin, and a high microvessel density was found to be correlated with granuloma formation in the skin [19] . There was also a correlation between high vascular density and the presence of ocular manifestations [19] .…”
Section: Inhibition Of Angiogenesismentioning
confidence: 98%
See 1 more Smart Citation
“…Mast cells may participate in a complex multifactorial process to promote localized vasodilation, angiogenesis, and tissue fibrosis. 33 Flushing may involve the nervous system, since symptoms of rosacea are triggered when patients are under emotional stress. [34][35][36] One active form of cathelicidin found in rosacea is LL-37.…”
Section: Chronic Vasodilationmentioning
confidence: 99%